What Now: Xylazine in the Age of Opioid Use Disorder

As the opioid use crisis continues to progress, communities across the country are now being faced with additional dangers such as the misuse of xylazine, a powerful sedative commonly used for animals, in the drug supply. Recent studies indicate this potent substance, when used with opioids, increases overdose risk and complicates treatment and long-term healthcare.

Educational Objectives:

• Discuss the context of opioid and veterinary medicine misuse in rural and urban areas.
• Describe effective strategies to address medical issues associated with xylazine misuse.
• Examine prevention and treatment options for opioid and xylazine misuse.

Featured Speaker:

• Daniel Rosa, MD, FASAM, Sr. Medical Director, Acacia Network (New York City); Attending Physician, Emergency Medicine Philadelphia VA Medical Center

Funding for this initiative was made possible by cooperative agreement No. 1H79TI086770 from the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the U.S. Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government